Immunotherapy Pushes Cancer Toward Cure for Some Patients
Immunotherapy is maturing from research into real-life cancer care, with trials like dostarlimab showing tumor eradication without surgery in some patients. Researchers are expanding strategies—checkpoint inhibitors, CAR T-cell therapies, cancer vaccines, and treatment combinations—to boost response rates. While benefits can be life-changing, side effects exist and only a minority of tumors currently fit the best-immunotherapy profile, prompting a push toward personalized, multi-pronged approaches to help more patients.
